Researchers at Wake Forest University School of Medicine conducted a Phase III randomized, placebo-controlled trial to test donepezil, a cognitive-enhancing medicine used in the treatment of Alzheimer’s disease. The research team found that donepezil did not improve memory or other cognitive functions in survivors with cancer-related cognitive impairment.
Grateful Patient Returns to Hackensack University Medical Center to Motivate Patients & Team Members During National Hospital Week 2024
The National Comprehensive Cancer Network participates in meetings hosted by Maria Sklodowska-Curie National Research Institute of Oncology, the Polish Oncological Society, and Alliance for Innovation to advance work adapting proven cancer treatment guidelines for Poland.
Hearst Health and the UCLA Center for SMART Health today announced that a panel of expert judges has selected Mount Sinai Health System and The University of Texas MD Anderson Cancer Center as the 2024 Hearst Health Prize finalists. The winner will be announced at UCLA Health Data Day on June 4, 2024.
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced it is in advanced discussions with Memorial Sloan Kettering Cancer Center (MSK) to initiate a preclinical study evaluating MIRA's novel oral ketamine analog, Ketamir-2, for the treatment of cancer-related pain and depression.
The University of Illinois Chicago study will be the first to assess whether the natural product has anti-cancer effects that could benefit patients as they await surgical treatment.
The NCCN Guidelines for Patients: Small Bowel Adenocarcinoma are now available for free download at NCCN.org/patientguidelines, thanks to funding from the NCCN Foundation®.
May is both Brain Tumor Awareness Month and National Cancer Research Month. Virginia Tech’s Fralin Biomedical Research Institute at VTC is dedicated to advancing health through a better understanding of cancer and brain tumors and developing new ways to treat and prevent them.
Researchers at Washington University School of Medicine in St. Louis have found that a strain of gut bacteria can boost immune responses and enhance cancer immunotherapy to fight sarcoma tumors in mice. Shown is a rendering of microbes in the intestine.
In a trial analyzing how messages were framed in an underserved population, offering colorectal cancer screening options resulted in the highest screening rate
New research in The FASEB Journal indicates that expression levels of the RPGRIP1L gene might serve as a new prognostic marker for individuals with invasive breast cancer.
Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting, which will be held at the Walter E. Washington Convention Center in Washington, D.C., September 29 – October 2, 2024. Media registration is also available.
20221027104337.jpg&width=300&height=300)
The study, which joins a growing body of research on end-of-life cancer treatment, published May 16 in JAMA Oncology.
Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published today in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer Center and Yale Cancer Center.
Daniel M. Geynisman, MD, is being announced the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. Dr. Geynisman, Chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has a long history of working with NCCN in a variety of roles.
A new report from the American Association for Cancer Research explains the major drivers of cancer disparities and which groups are affected most. UChicago Medicine is prioritizing research initiatives that promote cancer equity.
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.
Today marks a significant milestone in cancer care with the introduction of bipartisan federal legislation that would revolutionize Medicare reimbursement for radiation therapy.
Lung cancer remains the leading cause of cancer-related deaths worldwide, with a significant portion of these deaths attributed to the aggressive nature of the disease and its resistance to traditional treatments. The study's findings offer a promising new avenue for therapeutic intervention by targeting the interaction between neutrophils and lung cancer cells, potentially improving patient outcomes.
Showing results
1–20 of 24794
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
